JP2021534799A5 - - Google Patents
Info
- Publication number
- JP2021534799A5 JP2021534799A5 JP2021511621A JP2021511621A JP2021534799A5 JP 2021534799 A5 JP2021534799 A5 JP 2021534799A5 JP 2021511621 A JP2021511621 A JP 2021511621A JP 2021511621 A JP2021511621 A JP 2021511621A JP 2021534799 A5 JP2021534799 A5 JP 2021534799A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- kit
- antisense oligomer
- target
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025071212A JP2025121926A (ja) | 2018-08-27 | 2025-04-23 | 肥満細胞のアポトーシスを誘導するためにスプライススイッチングオリゴヌクレオチドを用いてKitを標的とする方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862723326P | 2018-08-27 | 2018-08-27 | |
| US62/723,326 | 2018-08-27 | ||
| PCT/US2019/048400 WO2020046985A1 (en) | 2018-08-27 | 2019-08-27 | Targeting kit with splice switching oligonucleotides to induce apoptosis of mast cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025071212A Division JP2025121926A (ja) | 2018-08-27 | 2025-04-23 | 肥満細胞のアポトーシスを誘導するためにスプライススイッチングオリゴヌクレオチドを用いてKitを標的とする方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021534799A JP2021534799A (ja) | 2021-12-16 |
| JP2021534799A5 true JP2021534799A5 (cg-RX-API-DMAC10.html) | 2022-09-05 |
| JP7677628B2 JP7677628B2 (ja) | 2025-05-15 |
Family
ID=69644689
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511621A Active JP7677628B2 (ja) | 2018-08-27 | 2019-08-27 | 肥満細胞のアポトーシスを誘導するためにスプライススイッチングオリゴヌクレオチドを用いてKitを標的とする方法 |
| JP2025071212A Pending JP2025121926A (ja) | 2018-08-27 | 2025-04-23 | 肥満細胞のアポトーシスを誘導するためにスプライススイッチングオリゴヌクレオチドを用いてKitを標的とする方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025071212A Pending JP2025121926A (ja) | 2018-08-27 | 2025-04-23 | 肥満細胞のアポトーシスを誘導するためにスプライススイッチングオリゴヌクレオチドを用いてKitを標的とする方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210363531A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3844278A4 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7677628B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN112771162B (cg-RX-API-DMAC10.html) |
| CA (1) | CA3110353A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020046985A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017136435A1 (en) | 2016-02-01 | 2017-08-10 | The Usa, As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer National Institute Of Health | Compounds for modulating fc-epsilon-ri-beta expression and uses thereof |
| EP4054639A4 (en) | 2019-11-08 | 2025-04-30 | North Carolina State University | EXON SKIPPING OF FC-EPSILON-RI-BETA AND MS4A6A IN COMBINATION FOR THE TREATMENT OF ALLERGIC DISEASES |
| WO2025231071A1 (en) * | 2024-05-01 | 2025-11-06 | Beam Therapeutics Inc. | Compositions and methods for cell conditioning |
| CN121177520B (zh) * | 2025-11-24 | 2026-03-27 | 首都医科大学附属北京口腔医院 | 含有c-Kit的生物制品及其在调控牙源性器官组织发育中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0676470A1 (en) * | 1989-10-16 | 1995-10-11 | Amgen Inc. | Stem cell factor |
| US5989849A (en) * | 1991-05-09 | 1999-11-23 | Temple University Of The Commonwealth System Of Higher Education | Antisense of oligonucleotides to c-kit proto-oncogene and in vitro methods |
| EP0580795A4 (en) | 1991-05-09 | 1995-11-15 | Univ Temple | Antisense oligonucleotides to c-kit proto-oncogene and uses thereof |
| US5641625A (en) * | 1992-05-22 | 1997-06-24 | Isis Pharmaceuticals, Inc. | Cleaving double-stranded DNA with peptide nucleic acids |
| US7517864B2 (en) * | 2001-05-18 | 2009-04-14 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| WO2004009541A2 (en) * | 2002-07-19 | 2004-01-29 | Pharmacia Corporation | Antisense modulation of endothelial lipase expression |
| EP2305813A3 (en) * | 2002-11-14 | 2012-03-28 | Dharmacon, Inc. | Fuctional and hyperfunctional sirna |
| ES2627917T3 (es) * | 2004-06-28 | 2017-08-01 | The University Of Western Australia | Oligonucleótidos no codificantes para la inducción de la omisión exónica y métodos de uso de los mismos |
| WO2007028065A2 (en) * | 2005-08-30 | 2007-03-08 | Isis Pharmaceuticals, Inc. | Chimeric oligomeric compounds for modulation of splicing |
| US8178503B2 (en) * | 2006-03-03 | 2012-05-15 | International Business Machines Corporation | Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes |
| CA2947270A1 (en) * | 2014-04-28 | 2015-11-05 | Rxi Pharmaceuticals Corporation | Methods for treating cancer using nucleic acids targeting mdm2 or mycn |
| EP2985343A1 (en) * | 2014-08-11 | 2016-02-17 | Karlsruher Institut für Technologie | In vitro-co-culturesystem |
-
2019
- 2019-08-27 EP EP19853725.0A patent/EP3844278A4/en active Pending
- 2019-08-27 US US17/272,190 patent/US20210363531A1/en active Pending
- 2019-08-27 CA CA3110353A patent/CA3110353A1/en active Pending
- 2019-08-27 CN CN201980063706.3A patent/CN112771162B/zh active Active
- 2019-08-27 WO PCT/US2019/048400 patent/WO2020046985A1/en not_active Ceased
- 2019-08-27 JP JP2021511621A patent/JP7677628B2/ja active Active
-
2025
- 2025-04-23 JP JP2025071212A patent/JP2025121926A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Burgerhout et al. | Genetic background and embryonic temperature affect DNA methylation and expression of myogenin and muscle development in Atlantic salmon (Salmo salar) | |
| KR20190091708A (ko) | 한우육의 동일성 확인용 바이오 마커 및 이의 용도 | |
| Schmutz et al. | MITF and white spotting in dogs: a population study | |
| US20210017580A1 (en) | Small rna detection method based on small rna primed xenosensor module amplification | |
| CN111690755A (zh) | 提高尼罗罗非鱼选育效率的标记、方法、试剂盒及应用 | |
| JP2023501347A5 (cg-RX-API-DMAC10.html) | ||
| Rbbani et al. | The novel circular RNA CircMef2c is positively associated with muscle growth in Nile tilapia | |
| US11359245B2 (en) | Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions | |
| US20120183958A1 (en) | Methods for predicting fat and lean phenotypes in chickens | |
| KR101624342B1 (ko) | 흑돈육과 비흑돈육 판별에 유용한 단일염기다형성 마커 및 이의 용도 | |
| KR102615877B1 (ko) | 난축맛돈 돼지육 판별용 조성물 및 이의 용도 | |
| CA3244298A1 (en) | TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELL VARIANTS 2 (TREM2) AND ITS USES IN THE TREATMENT OF ALZHEIMER'S DISEASE | |
| Singh et al. | Genetic polymorphism and sequence evolution of an alternatively spliced exon of the glial fibrillary acidic protein gene, GFAP☆ | |
| CN114480497B (zh) | 一种ep400基因敲除斑马鱼心力衰竭模型的构建及其应用的方法 | |
| CN120041455A (zh) | 构建TBX19 p.Thr187Ala点突变小鼠模型的试剂盒及其构建方法和应用 | |
| CN118389710B (zh) | 一种与鸡开产日龄性状相关的tdh基因分子标记及其应用 | |
| CN104975097A (zh) | 绿壳蛋鸡啄羽相关基因检测用试剂盒及其实现方法 | |
| CN118685454A (zh) | 一种自发性胰腺癌小鼠模型及其构建方法和应用 | |
| JP2004524801A5 (cg-RX-API-DMAC10.html) | ||
| Wu et al. | C-fos regulates neuropeptide Y expression in mouse dentate gyrus | |
| EP4349983A1 (en) | Genome editing method | |
| Guo et al. | Transcription of human zinc finger ZNF268 gene requires an intragenic promoter element | |
| CN108531616A (zh) | 一种牦牛体格相关的基因分子标记、检测方法和试剂盒 | |
| Calva et al. | Discovery of SMAD4 promoters, transcription factor binding sites and deletions in juvenile polyposis patients | |
| WO2023018938A1 (en) | Methods for generation of precise rna transcripts |